Your browser doesn't support javascript.
loading
CNS activity of trastuzumab deruxtecan in HER2-expressing non-small-cell lung cancer.
Lazaratos, Anna-Maria; Petrecca, Kevin; Guiot, Marie-Christine; Jerzak, Katarzyna J; Dankner, Matthew.
Afiliação
  • Lazaratos AM; Rosalind and Morris Goodman Cancer Research Institute, McGill University, Montreal, QC H3A 1A3, Canada.
  • Petrecca K; Montreal Neurological Institute-Hospital, McGill University, Montreal, QC H3A 1A3, Canada.
  • Guiot MC; Montreal Neurological Institute-Hospital, McGill University, Montreal, QC H3A 1A3, Canada.
  • Jerzak KJ; Division of Medical Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Dankner M; Rosalind and Morris Goodman Cancer Research Institute, McGill University, Montreal, QC H3A 1A3, Canada. Electronic address: matthew.dankner@mail.mcgill.ca.
Lancet Oncol ; 25(7): e282, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38936381

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camptotecina / Carcinoma Pulmonar de Células não Pequenas / Receptor ErbB-2 / Trastuzumab / Neoplasias Pulmonares Limite: Female / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camptotecina / Carcinoma Pulmonar de Células não Pequenas / Receptor ErbB-2 / Trastuzumab / Neoplasias Pulmonares Limite: Female / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article